Dermal templates and the wound-healing paradigm: The promise of tissue regeneration

Expert Review of Medical Devices

Volumn 3, Issue 4, 2006, Pages 471-484

  Simpson, David G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Collagen; Dermal template; Dermis; Electrospinning; Epithelium; Fibrinogen; Growth factor; Keloid; Keratinocyte; Myofibroblast; Regeneration; Scar; Skin; TGF; Wound healing

Indexed keywords

BIOMATERIAL; CALCIUM ANTAGONIST; COLLAGEN; JUVISTA; NYLON; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; SILICONE; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VERAPAMIL;

BANDAGE; CLINICAL TRIAL; DERMIS; DRUG MECHANISM; HUMAN; NANOTECHNOLOGY; NONHUMAN; REVIEW; SCAR FORMATION; SKIN ABRASION; SKIN GRAFT; SKIN INJURY; SKIN STRUCTURE; SKIN TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND CARE; WOUND DRESSING; WOUND HEALING;

ANIMALS; CICATRIX; HUMANS; REGENERATION; SKIN; TISSUE ENGINEERING; WOUND HEALING;

EID: 33746612733     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.4.471     Document Type: Review

References (122)

1. Yannas IV. Regeneration Templates. The Biomedical Engineering Handbook: Second Edition. Bronzino JD (Ed.). CRC press LLC, FL, USA (2000).
2. Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing - review of the literature. Burns 8, 944-956 (2005).
3. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 9, 283-289 (2004).
4. Lever WF. Histopathology of the Skin. Gundula Schaumburg-Lever (Ed). Lippincott, PA, USA (1990).
5. Fuchs E. Epidermal differentiation: the bare essentials. J. Cell Biol. 111, 2807 (1990).
6. Wysocki AB. Skin anatomy, physiology, and pathophysiology. Nurs. Clin. North Am. 34(4), 777-797 (1999).
7. Keene DR, Marinkovich MP, Sakai LY. Immunodissection of the connective tissue matrix in human skin. Microsc. Res. Tech. 38(4), 394-406 (1997).
8. Barton SP, Marks R. Measurement of collagen-fibre diameter in human skin. J. Cutan. Pathol. 11(1), 18-26 (1984).
9. Stewart KJ. A quantitative ultrastructural study of collagen fibrils in human skin, normal scars, and hypertrophic scars. Clin. Anat. 8(5), 334-338 (1995).
10. Parry DAD, Barnes GRG, Craig AS. A comparison of the size distribution of collagen fibrils in connective tissues as a function of age and a possible relation between fibril size distribution and mechanical properties. Proceedings Royal Society of London. 203(1152), 305-321 (1978).
11. Kielty CM, Shuttleworth CA. Microfibrillar elements of the dermal matrix. Microsc. Res. Tech. 38(4), 413-427 (1997).
12. Li B, Daggett V. Molecular basis for the extensibility of elastin. J. Muscle Res. Cell. Motil. 23(5-6), 561-573 (2002).
13. Yasui T, Tohno Y, Araki T. Characterization of collagen orientation in human dermis by two-dimensional second-harmonic-generation polarimetry. J. Biomed. Opt. 9(2), 259-264 (2004).
14. Vaezy S, Smith LT, Milaninia A, Clark JI. Two-dimensional fourier analysis of electron micrographs of human skin for quantification of the collagen fiber organization in the dermis. J. Electron. Microsc. (Tokyo) 44(5), 358-364 (1995).
15. Junqueira LC, Carneiro J. Basic Histology: Text and Atlas. McGraw-Hill Companies, Inc., NY, USA (2005).
16. Smith LT, Holbrook KA. Development of dermal connective tissue in human embryonic and fetal skin. Scan. Electron Microsc. (Pt 4), 1745-1751 (1982).
17. Leblond CP, Inoue S. Structure, composition, and assembly of basement membrane. Am. J. Anat. 185, 367-390 (1989).
18. Uitto J, Pulkkinen L. Molecular complexity of the cutaneous basement membrane zone. Mol. Biol. Rep. 23(1), 35-46 (1996).
19. Yannas LV, Burke JF. Design of an artificial skin. I. Basic design principles. J. Biomater. Res. 14, 65-81 (1980).
20. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. J. Biomed. Mater. Res. 14(2), 107-132 (1980).
21. Dagalakis N, Flink J, Stasikelis P, Burke JF, Yannas IV. Design of an artificial skin. Part III. Control of pore structure. J. Biomed. Mater. Res. 14(4), 511-528 (1980).
22. Yannas IV. Regeneration Templates. The Biomedical Engineering Handbook: Second Edition. Bronzino JD (Ed.). CRC press LLC, FL, USA (2000).
23. Tran KT, Griffith L, Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen. 12(3), 262-268 (2004).
24. Davidson JM. Growth factors, extracellular matrix, and wound healing. In: Wound Healing Alternatives in Management (Third Edition). Kloth LC, McCulloch JM (Eds). F.A. Davis, PA, USA, 129-149 (2002).
25. Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, Barbarisi A. Smart materials as scaffolds for tissue engineering. J. Cell Physiol. 203(3), 465-470 (2005).
26. Hubbell JA. Materials as morphogenetic guides in tissue engineering. Curr. Opin. Biotechnol. 14(5), 551-558 (2003).
27. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnol. 23(1), 47-55 (2005).
28. Simpson DG, Terracio L, Terracio M, Price RL, Turner DC, Borg TK. Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix. J. Cell Physiol. 161, 89-105 (1994).
29. Simpson DG. Integrins. Encyclopedia of Biomaterials and Biomedical Engineering. Wnek GE, Bowlin GL (Eds). Marcel Dekker, NY, USA (2006).
30. Yost MT, Simpson DG, Borg TK, Terracio L. Design and construction of a Uniaxial cell stretcher: cardiac fibroblast response to stretch. Am. J. Pathol. 279, H3124-H3130 (2000).
31. Falanga V. Cutaneous Wound Healing. Taylor & Francis, UK (2001).
32. Sussman C. Wound healing biology and chronic wound healing. In: Wound Care: a Collaborative Practice Manual for Physical Therapists and Nurses. Sussman C, Bates-Jensen BM (Eds). Aspen, MD, USA (1998).
33. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J. Clin. Invest. 95(5), 2281-2290 (1995).
34. Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab. Invest. 78(1), 47-58 (1998).
35. Reed MJ, Ferara NS, Vernon RB. Impaired migration, integrin function, and actin cytoskeletal organization in dermal fibroblasts from a subset of aged human donors. Mech. Ageing Dev. 122(11), 1203-1220 (2001).
36. Gosiewska A, Yi CF, Brown LJ, Cullen B, Silcock D, Geesin JC. Differential expression and regulation of extracellular matrix-associated genes in fetal and neonatal fibroblasts. Wound Repair Regen. 9(3), 213-222 (2001).
37. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J. Histochem. Cytochem. 51(9), 1119-1130 (2003).
38. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J. Invest. Dermatol. 117(5), 1027-1035 (2001).
39. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast. Reconstr. Surg. 117(1), 286-300 (2006).
40. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen. 11(6), 411-418 (2003).
41. Roh C, Lyle S. Cutaneous stem cells and wound healing. Pediatr. Res. 59(4 Pt 2), 100R-103R (2006).
42. Satoh H, Kishi K, Tanaka T et al. Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds. Cell Transplant. 13(4), 405-412 (2004).
43. Nakagawa H, Akita S, Fukui M, Fujii T, Akino K. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br. J. Dermatol. 153(1), 29-36 (2005).
44. Riedel F, Philipp K, Sadick H, Goessler U, Hormann K, Verse T. Immunohistochemical analysis of radiation-induced non-healing dermal wounds of the head and neck. In Vivo 19(2), 343-350 (2005).
45. Liu X, Liu JZ, Zhang E et al. Impaired wound healing after local soft x-ray irradiation in rat skin: time course study of pathology, proliferation, cell cycle, and apoptosis. J. Trauma 59(3), 682-690 (2005).
46. Miller MC, Nanchahal J. Advances in the modulation of cutaneous wound healing and scarring. BioDrugs 19(6), 363-381 (2005).
47. Yao F, Visovatti S, Johnson CS et al. Age and growth factors in porcine full-thickness wound healing. Wound Repair Regen. 9(5), 371-377 (2001).
48. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol. Surg. 31(6), 674-686 (2005).
49. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83(3), 835-970 (2003).
50. Stassen JM, Arnout J, Deckmyn H. The hemostatic system. Curr. Med. Chem. (17), 2245-2260 (2004).
51. Moulin V. Growth factors in skin wound healing. Eur. J. Cell Biol. 68(1), 1-7 (1995).
52. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am. J. Surg. 165(6), 728-737 (1993).
53. Goldman R. Growth factors and chronic wound healing: past, present, and future. Adv. Skin Wound Care 17(1), 24-35 (2004).
54. Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 15(4), 255-273 (2004).
55. Grose R, Werner S. Wound-healing studies in transgenic and knockout mice. Mol. Biotechnol. 28(2), 147-166 (2004).
56. Martin P, Hopkinson-Woolley J, McCluskey J. Growth factors and cutaneous wound repair. Prog. Growth Factor Res. 4(1), 25-44 (1992).
57. Nathan C. Neutrophils and immunity: challenges and opportunities. Nature Rev. Immunol. 6(3), 173-182 (2006).
58. DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock 4(4), 233-240 (1995).
59. Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am. J. Surg. 187(5A), 11S-16S (2004).
60. Szpaderska AM, DiPietro LA. Inflammation in surgical wound healing: friend or foe? Surgery 137(5), 571-573 (2005).
61. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 15(11), 599-607 (2005).
62. Pascarella L, Schonbein GW, Bergan JJ. Microcirculation and venous ulcers: a review. Ann. Vasc. Surg. 19(6), 921-927 (2005).
63. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 13(1), 7-12 (2005).
64. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc. 5(1), 40-46 (2000).
65. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60(1), 107-114 (2003).
66. El Ghalbzouri A, Hensbergen P, Gibbs S, Kempenaar J, van der Schors R, Ponec M. Fibroblasts facilitate re-epithelialization in wounded human skin equivalents. Lab. Invest. 84(1), 102-112 (2004).
67. El Ghalbzouri A, Jonkman MF, Dijkman R, Ponec M. Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/ or exogenously activated keratinocytes. J. Invest. Dermatol. 124(1), 79-86 (2005).
68. Krejci-Papa NC, Hoang A, Hansbrough JF. Fibroblast sheets enable epithelialzation of sounds that do not support keratinocyte migration. Tissue Eng. 5(6), 555-562 (1999).
69. Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp. Cell Res. 304(1), 274-286 (2005).
70. Black AF, Bouez C, Perrier E, Schlotmann K, Chapuis F, Damour O. Optimization and characterization of an engineered human skin equivalent. Tissue Eng. 11(5-6), 723-733 (2005).
71. Lacroix M, Bovy T, Nusgens BV, Lapiere CM. Keratinocytes modulate the biosynthetic phenotype of dermal fibroblasts at a pretranslational level in a human skin equivalent. Arch. Dermatol. Res. 287(7), 659-664 (1995).
72. Greenhalgh DG. The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30(9), 1019-1030 (1998).
73. Edwards M, Jones D. Programmed cell death in human acute cutaneous wounds. J. Cutan. Pathol. 28(3), 151-155 (2001).
74. Colwell AS, Longaker MT, Lorenz HP. Fetal wound healing. Front. Biosci. 1(8), s1240-s1248 (2003).
75. Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp. Cell Res. 257(1), 180-189 (2000).
76. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol. 159(3), 1009-1020 (2001).
77. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124(4), 401-404 (1994).
78. van Zuijlen PP, Ruurda JJ, van Veen HA et al. Collagen morphology in human skin and scar tissue: no adaptations in response to mechanical loading at joints. Burns 29(5), 423-431 (2003).
79. Berry DP, Harding KG, Stanton MR, Jasani B, Ehrlich HP. Human wound contraction: collagen organization, fibroblasts, and myofibroblasts. Plast. Reconstr. Surg. 102(1), 124-131 (1998).
80. Wang JH, Jia F, Gilbert TW, Woo SL. Cell orientation determines the alignment of cell-produced collagenous matrix. J. Biomech. 36(1), 97-102 (2003).
81. Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am. J. Clin. Dermatol. 4(4), 235-243 (2003).
82. Chen MA, Davidson TM. Scar management: prevention and treatment strategies. Curr. Opin. Otolaryngol. Head Neck Surg. 13(4), 242-247 (2005).
83. Van den Kerckhove E, Stappaerts K, Boeckx W et al. Silicones in the rehabilitation of burns: a review and overview. Burns 27(3), 205-214 (2001).
84. Wagner W, Alfrink M, Micke O, Schafer U, Schuller P, Willich N. Results of prophylactic irradiation in patients with resected keloids - a retrospective analysis. Acta Oncol. 39(2), 217-220 (2000).
85. D'Andrea F, Brongo S, Ferraro G, Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology 204 (1), 60-62 (2002).
86. Chen W, Fu X, Ge S et al. Ontogeny of expression of transforming growth factor-β and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen. 13(1), 68-75 (2005).
87. O'Kane S, Ferguson MW. Transforming growth factor βs and wound healing. Int. J. Biochem. Cell Biol. 29(1), 63-78 (1997).
88. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359(1445), 839-850 (2004).
89. Soma Y, Mizoguchi M, Yamane K et al. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-β1. Arch. Dermatol. Res. 293(12), 609-613 (2002).
90. Wadman M. Scar prevention: the healing touch. Nature 436, 1079-1080 (2005).
91. Bradley DT, Park SS. Scar revision via resurfacing. Facial Plast. Surg. 17(4), 253-262 (2001)
92. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 21(4), 243-248 (1995).
93. Tan L, Williams MA, Khan MK, Champion HC, Nielsen NH. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific Affairs. American Medical Association. JAMA 281(24), 2330-2339 (1999).
94. Bradley R. Bovine spongiform encephalopathy. Update. Acta Neurobiol. Exp. (Wars) 62 (3), 183-195 (2002).
95. Bird SM. European Union's rapid TSE testing in adult cattle and sheep: implementation and results in 2001 and 2002. Stat. Methods Med. Res. 12(3), 261-278 (2003).
96. Hansbrough JF, Zapata-Sirvent R, Carroll WJ, Dominic WJ, Wang XW, Wakimoto A. Clinical experience with Biobrane biosynthetic dressing in the treatment of partial thickness burns. Burns Incl. Therm. Inj. 10(6), 415-419 (1984).
97. Purdue GF, Hunt JL, Gillespie RW et al. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J. Trauma. 27(2), 155-157 (1987).
98. Gobet R, Raghunath M, Altermatt S et al. Efficacy of cultured epithelial autografts in pediatric burns and reconstructive surgery. Surgery 121(6), 654-661 (1997).
99. Murphy GF, Orgill DP, Yannas IV. Partial dermal regeneration is induced by biodegradable collagen-glycosaminoglycan grafts. Lab. Invest. 62(3), 305-313 (1990).
100. Stern R, McPherson M, Longaker MT. Histologic study of artificial skin used in the treatment of full-thickness thermal injury. J. Burn Care Rehabil. 11 (1), 7-13 (1990).
101. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl Acad. Sci. USA 76(11), 5665-5668 (1979).
102. Longaker MT, Adzick NS, Hall JL et al. Studies in fetal wound healing, VII. Fetal wound healing may be modulated by hyaluronic acid stimulating activity in amniotic fluid. J. Pediatr. Surg. 25(4), 430-433 (1990).
103. Still J, Glat P, Silverstein P, Griswold J, Mozingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 29(8), 837-841 (2003).
104. Marston WA, Hanft J, Norwood P, Pollak R; Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26(6), 1701-1705 (2003).
105. Rhudy RW, McPherson JM. Influence of the extracellular matrix on the proliferative response of human skin fibroblasts to serum and purified platelet-derived growth factor. J. Cell Physiol. 137, 185-191 (1988).
106. Pereira M, Simpson-Haidaris PJ. Fibrinogen modulates gene expression in wounded fibroblasts. Ann. N Y Acad. Sci. 936, 438-443 (2001).
107. Longaker MT, Whitby DJ, Ferguson MW, Lorenz HP, Harrison MR, Adzick NS. Adult skin wounds in the fetal environment heal with scar formation. Ann. Surg. 219(1), 65-72 (1994).
108. Lanning DA, Nwomeh BC, Montante SJ, Yager DR, Diegelmann RF, Haynes JH. TGF-β1 alters the healing of cutaneous fetal excisional wounds. J. Pediatr. Surg. 34(5), 695-700 (1999).
109. Miller MC, Nanchahal J. Advances in the modulation of cutaneous wound healing and scarring. BioDrugs 19(6), 363-381 (2005).
110. Brown DM, Barton BR, Young VL, Pruitt BA. Decreased wound contraction with fibrin glue - treated skin grafts. Arch. Surg. 127(4), 404-406 (1992).
111. Wnek GE, Carr ME, Simpson DG, Bowlin GL. Electrospinning of nanofiber fibrinogen structures. Nano Letters 2, 213-216 (2003).
112. McManus MC, Boland ED, Koo HP et al. Mechanical properties of electrospun fibrinogen structures. Acta biomaterialia 2(1), 19-28 (2006).
113. Telemeco TA, Ayres CE, Bowlin GL et al. Regulation of cellular infiltration into tissue engineering scaffolds composed of submicron diameter fibrils produced by electrospinning. Acta Biomaterialia 1, 377-385 (2005).
114. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning collagen nanofibers. Biomacromolecules 3, 232-238 (2002).
115. Sell SA, McClure MJ, Barnes CP et al. Electrospun polydioxanone elastin blends: potential for bioresorbable vascular grafts. Biomed. Mater. 1, 72-80 (2006).
116. Boland ED, Coleman BD, Barnes CP, Simpson DG, Wnek GE, Bowlin GL. Electrospinning polydioxanone for biomedical applications. Acta Biomaterialia 1(1), 115-123 (2005).
117. Simpson DG, Bowlin GL. Tissue-engineering scaffolds: can we re-engineer mother nature? Expert Rev. Med. Devices 3(1), 9-15 (2006).
118. Kenawy EJ, Layman J, Watkins JR et al. Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. Biomaterials 24(6), 907-913 (2003).
119. Sanders EH, Kloefkorn R, Bolwin GL, Simpson DG, Wnek GE. Two-phase electrospinning from a single electrified jet: microencapsulation of aqueous reservoirs in poly(ethylene-co-vinly acetate) fibers. Macromolecules 36, 3803-3805 (2003).
120. Kenawy E, Mansfield K, Bowlin GL, Simpson DG, Wnek GE. New drug delivery system: control release of tetracycline hydrochloride as a model drug from electrospun fibers of poly(lactic acid) and poly(ethylene vinyl acetate). J. Control. Release 81, 57 (2002).
121. Telemeco T, Ellis R, Bowman J, Bowlin GL, Simpson DG. Matrix metalloproteinases in bioengineering interventions. In: Encyclopedia of Biomaterials and Biomedical Engineering. Wnek GE, Bowlin GL (Eds). Marcel Dekker, NY, USA (2004).
122. Ayres CE, Bowlin GL, Henderson SC et al. Modulation of anisotropy in electrospun tissue engineering scaffolds: analysis of fiber alignment by the fast fourier transform. Biomaterials (2006) (In press).